4//SEC Filing
LIEBER RANDY 4
Accession 0001056520-09-000485
CIK 0001325279other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 8:40 PM ET
Size
12.4 KB
Accession
0001056520-09-000485
Insider Transaction Report
Form 4
LIEBER RANDY
DirectorPrincipal Accounting Officer
Transactions
- Award
Common Stock
2009-08-21$0.68/sh+110,000$74,800→ 978,768 total - Award
Options
2009-05-20+1,000,000→ 1,000,000 totalExercise: $0.07Exp: 2014-05-19→ Common (1,000,000 underlying) - Award
Options
2009-09-17+1,000,000→ 4,000,000 totalExercise: $0.05Exp: 2011-09-16→ Common (1,000,000 underlying) - Award
Options
2009-05-20+2,000,000→ 3,000,000 totalExercise: $0.07Exp: 2014-05-19→ Common (2,000,000 underlying)
Footnotes (2)
- [F1]The Board of Directors authorized the issuance of these options on May 20, 2009, as compensation for services as an officer and board member; however, the options were not issued until 9/22/2009. The exercise price of these options reflect CellCyte's market price at May 20, 2009, which was higher than CellCyte's market price on September 22, 2009, the issuance date. The options become exercisable linearly over 4 quarters, beginning with the quarter in which the options were granted.
- [F2]The Issuer granted these options in consideration of the guarantee for payment of a contract owed by the Issuer. The options are exercisable on the transaction date.
Documents
Issuer
CELLCYTE GENETICS CORP
CIK 0001325279
Entity typeother
Related Parties
1- filerCIK 0001465074
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 8:40 PM ET
- Size
- 12.4 KB